|
2026 Journal Article Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum DisordersKulin, Dmitrii, Holtmann, Gerald, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Drossman, Douglas A., Jones, Michael P., Aziz, Qasim and Shah, Ayesha (2026). Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders. Alimentary Pharmacology & Therapeutics apt.70856. doi: 10.1111/apt.70856 |
|
2026 Journal Article Study of TOfacitinib for the treatment of chronic PouchITis (STOPit): a multi-centre open label induction with randomised, double blind, placebo-controlled maintenance trialKhoo, Emi, Holtmann, Gerald and Begun, Jakob (2026). Study of TOfacitinib for the treatment of chronic PouchITis (STOPit): a multi-centre open label induction with randomised, double blind, placebo-controlled maintenance trial. BMJ Open, 16 (7) e118940, e118940-7. doi: 10.1136/bmjopen-2026-118940 |
|
2026 Journal Article The challenges of performing controlled trials of diet therapies in gastroenterologyDay, Alice S., Yao, Chu K., Ford, Alexander C., Holtmann, Gerald and Halmos, Emma P. (2026). The challenges of performing controlled trials of diet therapies in gastroenterology. JGH Open, 10 (7) e70439. doi: 10.1002/jgh3.70439 |
|
2026 Journal Article Hospital-admitted injection-related infections among incarcerated people who inject drugs in Australia: a retrospective cohort studyPalmer, Andrew, Carter, Matthew, Yeo, Jeremy, Shim, Cecilia, Connor, Jason, Hayllar, Jeremy, Holtmann, Gerald, Moy, Naomi, Playford, Elliott G., Runnegar, Naomi and Clark, Paul J. (2026). Hospital-admitted injection-related infections among incarcerated people who inject drugs in Australia: a retrospective cohort study. Medical Journal of Australia, 224 (6). doi: 10.5694/mja2.70224 |
|
2026 Journal Article Role of anxiety and depression on the interplay between disorders of gut-brain interaction and eating disordersEgboh, SC, Koloski, NA, Jones, MP, Shah, A, Holtmann, G and Talley, NJ (2026). ROLE OF ANXIETY AND DEPRESSION ON THE INTERPLAY BETWEEN DISORDERS OF GUT-BRAIN INTERACTION AND EATING DISORDERS. Clinical and Translational Gastroenterology, Publish Ahead of Print 10.14309/ctg.0000000000001025. doi: 10.14309/ctg.0000000000001025 |
|
2026 Journal Article Impact of bariatric surgery on alcohol‐use disorder and alcohol‐related liver disease: a retrospective studyWilliams, Thomas J., Palmer, Andrew J., Connor, Jason P., Holtmann, Gerald and Clark, Paul J. (2026). Impact of bariatric surgery on alcohol‐use disorder and alcohol‐related liver disease: a retrospective study. Addiction add.70487. doi: 10.1111/add.70487 |
|
2026 Conference Publication IDDF2026-ABS-0193 Development and validation of GI symptoms animated pictograms (GAPs) as a diagnostic tool for gi dysfunction among patients with cognitive impairmentEhab Samir Ayad, Mina, Yeh Lee, Yeong, Holtmann, Gerald, Kuo, Braden, Schmulson, Max, Viet Hang, Dao, Ghoshal, Uday, Marie Lawenko, Rona, Miftahussurur, Muhammad, Ali, Enaam, Faizal, Mohd, Kueh, Erica and Oshima, Tadayuki (2026). IDDF2026-ABS-0193 Development and validation of GI symptoms animated pictograms (GAPs) as a diagnostic tool for gi dysfunction among patients with cognitive impairment. BMJ Publishing Group Ltd and British Society of Gastroenterology. doi: 10.1136/gutjnl-2026-iddf.271 |
|
2026 Journal Article A clinical practice update for the management of patients with disorders of gut-brain interaction and altered food intake behaviorShah, Ayesha, Talley, Nicholas J., Knowles, Simon R., Duncanson, Kerith, Koloski, Natasha, Connor, Jason P., Day, Andrew S., Almehdawy, Basil, Basnayake, Chamara, Burgell, Rebecca, Carey, Sharon, Cock, Charles, Daker, Charlotte, Kaushik, Vishal, Kent, Dan, Kellar, Trina, Lane, Katherine, Martin, Neal, Malcolm, Allison, Murphy, Kate Elizabeth, Sharp, Gemma, Tuck, Caroline, Jones, Michael, Thapar, Nikhil and Holtmann, Gerald (2026). A clinical practice update for the management of patients with disorders of gut-brain interaction and altered food intake behavior. Neurogastroenterology and Motility, 38 (5) e70337. doi: 10.1111/nmo.70337 |
|
2026 Conference Publication Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTIONFairlie, Thomas, Celine, Patricia, Shah, Ayesha, Lim, Yenkai, Morrison, Mark and Holtmann, Gerald (2026). Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION. Elsevier BV. doi: 10.1016/s0016-5085(26)05814-2 |
|
2026 Journal Article Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth ( <scp>SIBO</scp> )Shah, Ayesha, Holtmann, Gerald and Gibson, Peter R. (2026). Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth ( SIBO ). JGH Open, 10 (5) e70419. doi: 10.1002/jgh3.70419 |
|
2026 Journal Article Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEWWilmes, Sophie, Holtmann, Gerald, Shah, Ayesha and Moy, Naomi (2026). Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEW. Gastrointestinal Endoscopy, 103 (5), S-2343. doi: 10.1016/s0016-5107(26)05474-x |
|
2026 Conference Publication Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEWWilmes, Sophie, Holtmann, Gerald, Shah, Ayesha and Moy, Naomi (2026). Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEW. Elsevier BV. doi: 10.1016/s0016-5085(26)05543-5 |
|
2026 Journal Article Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKSGonsalves, Nirmala, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Ravikumar, Pranali, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKS. Gastrointestinal Endoscopy, 103 (5), S-817. doi: 10.1016/s0016-5107(26)02133-4 |
|
2026 Conference Publication 400 SINGLE ADMINISTRATION OF ESCALATING DOSES OF EP-104GI LEADS TO PERSISTENT IMPROVEMENTS IN HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS OVER 36 WEEKS IN RESOLVE, A PHASE 1B/2 DOSE ESCALATION AND OPTIMIZATION TRIALMa, Christopher, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Dobek, Christine, Dye, Andrew, Kowalski, Mark M. and Malone, Amanda (2026). 400 SINGLE ADMINISTRATION OF ESCALATING DOSES OF EP-104GI LEADS TO PERSISTENT IMPROVEMENTS IN HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS OVER 36 WEEKS IN RESOLVE, A PHASE 1B/2 DOSE ESCALATION AND OPTIMIZATION TRIAL. Elsevier BV. doi: 10.1016/s0016-5085(26)01797-x |
|
2026 Conference Publication Advancing hepatitis C elimination in prisons: a state-specific modelling study of integrated harm-reduction and addiction interventionsPalmer, Andrew, Anandan, Aathavan Shanmuga, Carter, Matthew, Fraz, Ezaam, Clark, Paul, Connor, Jason, Holtmann, Gerald, Runnegar, Naomi, Playford, Geoffrey, Hayllar, Jeremy, Scott, Nick and Houdroge, Farah (2026). Advancing hepatitis C elimination in prisons: a state-specific modelling study of integrated harm-reduction and addiction interventions. EASL Congress 2026, Barcelona, Spain, 27-30 May 2026. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(26)02182-3 |
|
2026 Conference Publication Prevalence of orthostatic intolerance in patients with disorders of gut-brain interaction: a systematic review and meta-analysisAyaki, Kana, Shah, Ayesha, Fairlie, Thomas, Kulin, Dmitrii, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Prevalence of orthostatic intolerance in patients with disorders of gut-brain interaction: a systematic review and meta-analysis. Digestive Disease Week (DDW) 2026, Chicago, IL, United States, 2-5 May 2026. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(26)04699-8 |
|
2026 Conference Publication 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBIShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI. Elsevier BV. doi: 10.1016/s0016-5085(26)05702-1 |
|
2026 Journal Article 400 SINGLE ADMINISTRATION OF ESCALATING DOSES OF EP-104GI LEADS TO PERSISTENT IMPROVEMENTS IN HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS OVER 36 WEEKS IN RESOLVE, A PHASE 1B/2 DOSE ESCALATION AND OPTIMIZATION TRIALMa, Christopher, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Dobek, Christine, Dye, Andrew, Kowalski, Mark M. and Malone, Amanda (2026). 400 SINGLE ADMINISTRATION OF ESCALATING DOSES OF EP-104GI LEADS TO PERSISTENT IMPROVEMENTS IN HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS OVER 36 WEEKS IN RESOLVE, A PHASE 1B/2 DOSE ESCALATION AND OPTIMIZATION TRIAL. Gastrointestinal Endoscopy, 103 (5), S-627. doi: 10.1016/s0016-5107(26)01728-1 |
|
2026 Conference Publication COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBIShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI. Digestive Disease Week (DDW), Chicago Il, May 02-05, 2026. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2026 Conference Publication A comparison of diagnostic methodologies for small intestinal bacterial overgrowth: aspirate culture, breath testing and the Atmo capsuleShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). A comparison of diagnostic methodologies for small intestinal bacterial overgrowth: aspirate culture, breath testing and the Atmo capsule. Digestive Disease Week (DDW) 2026, Chicago, IL, United States, 2-5 May 2026. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(26)05815-4 |
